Bacteriophages of the Scientific and Production Association Microgen of the Naсimbio holding (Rostec State Corporation) are used to prevent outbreaks of infectious diseases in the affected with the showers areas of the Kuban. More than 3,000 products were delivered to the region on Sunday.
Read more
SPA Microgen, part of the Naсimbio holding (Rostec State Corporation), has developed a new Russian drug for the treatment of primary immunodeficiency diseases. The drug, called BioGam, successfully passed the preclinical and Phase 1 of clinical studies that confirmed its safety.
Read more
SPA Microgen of the Naсimbio holding (part of Rostec State Corporation), together with leading Russian research institutions in the field of influenza prevention, based on the Irkutsk branch, created a new Russian live vaccine against a potentially pandemic H7N9 avian influenza virus.
Read more
The Scientific and Production Association Microgen of the Naсimbio holding (Rostec State Corporation) completed research on the expansion of indications for Relatox in the treatment of spastic forms of cerebral palsy in children aged 7 to 12 years
Read more
The Scientific and Production Association Microgen of the National Immunobiological Company (part of Rostec State Corporation) has developed a universal drug product that allows one capsule to replace the intake of a complex of traditional antimicrobial agents for infectious diseases treatment.
Read more
